Larson Financial Group’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15 Sell
5
-5,301
-100% -$22.5K ﹤0.01% 3595
2025
Q4
$19.2K Buy
5,306
+1
+0% +$4 ﹤0.01% 1751
2025
Q3
$20K Buy
5,305
+5
+0.1% +$19 ﹤0.01% 1648
2025
Q2
$20.5K Buy
5,300
+300
+6% +$1.62K ﹤0.01% 1479
2025
Q1
$25K Hold
5,000
﹤0.01% 1281
2024
Q4
$36K Hold
5,000
﹤0.01% 1005
2024
Q3
$30.7K Buy
+5,000
New +$33.9K ﹤0.01% 1059

Other funds holding ALT

Larson Financial Group's ALT Position: Q1 2026 in Review

Larson Financial Group reduced its Altimmune (ALT) stake by 100% in Q1 2026, selling an estimated $22.5K and leaving 5 shares worth $15. The position accounts for ﹤0.01% of the portfolio, ranked #3595.

Larson Financial Group first reported a position in ALT in Q3 2024 and has held it in 7 quarters since. The position peaked at $36K in Q4 2024. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Larson Financial Group held 5 shares of Altimmune worth $15 as of Q1 2026.
  • Larson Financial Group sold 5,301 Altimmune shares in Q1 2026, an estimated $22.5K.
  • Altimmune made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #3595 holding.
  • Larson Financial Group first reported a position in Altimmune in Q3 2024 and has held it in 7 quarters since.
  • Larson Financial Group's Altimmune position peaked at $36K in Q4 2024.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.